Heparin-Binding Protein in Critically Ill Children With Severe Community-Acquired Pneumonia

Caizhi Huang1, Cong Zhang1, Jie Zhang1

  • 1Department of Laboratory Medicine, Hunan Children's Hospital, Changsha, China.

Frontiers in Pediatrics
|November 15, 2021
PubMed

Insights

Heparin-binding protein (HBP) shows promise in predicting respiratory failure and sepsis progression in children with severe community-acquired pneumonia (CAP). Higher HBP levels were independently associated with respiratory failure and outperformed other biomarkers in predicting severe sepsis.

Area of Science:

  • Pediatric critical care medicine
  • Infectious diseases
  • Biomarker research

Background:

  • Severe community-acquired pneumonia (CAP) in children can lead to critical complications like respiratory failure (RF) and sepsis.
  • Identifying reliable biomarkers for early prediction of disease progression is crucial for timely intervention in critically ill children.

Purpose of the Study:

  • To investigate the association between Heparin-binding protein (HBP) levels and the development of RF and sepsis in children with severe CAP.
  • To evaluate HBP as a potential predictor of disease progression compared to established biomarkers.

Main Methods:

  • A cohort of 157 critically ill children with severe CAP admitted to the ICU was studied.
  • Plasma levels of HBP and other biomarkers (CRP, IL-6, procalcitonin, WBC, neutrophil percentage, D-dimer) were measured at ICU admission.
  • Development of RF and sepsis was monitored throughout the ICU stay.

Main Results:

  • Elevated HBP levels were observed in children with severe CAP.
  • HBP, IL-6, and D-dimer significantly predicted RF development; high HBP was independently associated with RF.
  • HBP demonstrated superior performance in predicting severe sepsis compared to other biomarkers, with high specificity and positive predictive value.

Conclusions:

  • Heparin-binding protein (HBP) may serve as a valuable and potentially superior biomarker for predicting disease progression, including respiratory failure and severe sepsis, in children with severe CAP.
  • Further research validating HBP's role in pediatric critical care is warranted.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
24
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.0K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
523
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
70
Drug Distribution: Plasma Protein Binding01:29

Drug Distribution: Plasma Protein Binding

Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
7.2K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
21